Juan Nácher
My impression is that, overall, this is a good article, with very interesting findings, particularly with regard to PTSD (post-traumatic stress disorder). It does, however, have some very significant limitations which call for caution when interpreting the results.
The study highlights differences in the epigenetics of various brain regions in PTSD. Although there was already evidence of these alterations in blood and saliva, this is the first time a comprehensive study has been carried out on post-mortem brains. Furthermore, the study reveals that epigenetic alterations do not occur uniformly across the brains of patients with PTSD; rather, there are substantial differences between different brain regions, which could indicate greater vulnerability in these regions or a greater impact of traumatic experiences on them. Of particular interest is the finding of a possible influence of traumatic experiences during adulthood on epigenomic modifications, as well as an apparent reduction in the number of oligodendrocytes—the myelin-producing cells—in the amygdala.
This is relevant because this region of the brain processes traumatic and fear-related memories, and many neuroimaging studies in humans with PTSD and in animal models of this condition have revealed structural and functional alterations. Alterations in the oligodendrocyte genome may influence the connectivity of amygdala neurons.
There are very significant limitations, which are inherent to working with post-mortem brains. The first is the absence of a conventional psychiatric assessment specifically for PTSD or MDD (major depressive disorder). Patients were selected primarily through retrospective telephone interviews with family members. This severely limits the observation of specific symptoms and the assessment of trauma (particularly if it occurred in childhood or adolescence). Nor is there any classification of patients according to the age of onset of the disorder or its duration. Although the number of cases is very large for a study using post-mortem material, the age range is enormous (18–85), and this may introduce significant bias. I do not have access to the detailed demographic table, but it does not appear that the variation in the time elapsed between death and the analysis or freezing of the samples has been taken into account. Nor does the influence of medication appear to have been considered, and this can have a very significant impact on epigenetics.